TARSUS PHARMACEUTICALS, INC. Adjustments to Additional Paid in Capital, Warrant Issued
TARSUS PHARMACEUTICALS, INC. (TARS) reported Adjustments to Additional Paid in Capital, Warrant Issued of $9.37 million for the 12-month period ending 2024-12-31, per its 10-K filed 2026-02-23.
Financial Statements › Shareholders' Equity › Adjustments to Additional Paid in Capital
us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued · last filed 2026-02-23
- TARSUS PHARMACEUTICALS, INC. adjustments to additional paid in capital, warrant issued for the quarter ending 2024-03-31 was $9.37M.
- TARSUS PHARMACEUTICALS, INC. adjustments to additional paid in capital, warrant issued for fiscal 2024 was $9.37M.
| Period end | Adjustments to Additional Paid in Capital, Warrant Issued 3 month | Adjustments to Additional Paid in Capital, Warrant Issued 12 month |
|---|---|---|
| 2024-12-31 | $9.37M 10-K · filed 2026-02-23 | |
| 2024-03-31 | $9.37M 10-Q · filed 2025-11-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Denali Therapeutics Inc. (DNLI) | United States | $3.274B | -8.04 |
| Relay Therapeutics, Inc. (RLAY) | United States | $3.884B | -14.30 |
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| Greenland Mines Ltd (GRML) | United States | $2.362B | |
| BIOCRYST PHARMACEUTICALS INC (BCRX) | United States | $2.175B | -6.63 |
| ADMA BIOLOGICS, INC. (ADMA) | United States | $2.131B | 11.16 |
| Kodiak Sciences Inc. (KOD) | United States | $2.090B | -10.12 |
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| Vericel Corp (VCEL) | United States | $2.011B | 93.97 |
| Adaptive Biotechnologies Corp (ADPT) | United States | $4.719B | -53.43 |